These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

164 related items for PubMed ID: 7728764

  • 1. Loss of P16INK4 expression is frequent in high grade gliomas.
    Nishikawa R, Furnari FB, Lin H, Arap W, Berger MS, Cavenee WK, Su Huang HJ.
    Cancer Res; 1995 May 01; 55(9):1941-5. PubMed ID: 7728764
    [Abstract] [Full Text] [Related]

  • 2. Malignant astrocytomas with homozygous CDKN2/p16 gene deletions have higher Ki-67 proliferation indices.
    Ono Y, Tamiya T, Ichikawa T, Kunishio K, Matsumoto K, Furuta T, Ohmoto T, Ueki K, Louis DN.
    J Neuropathol Exp Neurol; 1996 Oct 01; 55(10):1026-31. PubMed ID: 8857999
    [Abstract] [Full Text] [Related]

  • 3. Silencing of p16/CDKN2 expression in human gliomas by methylation and chromatin condensation.
    Costello JF, Berger MS, Huang HS, Cavenee WK.
    Cancer Res; 1996 May 15; 56(10):2405-10. PubMed ID: 8625319
    [Abstract] [Full Text] [Related]

  • 4. CDKN2/p16 or RB alterations occur in the majority of glioblastomas and are inversely correlated.
    Ueki K, Ono Y, Henson JW, Efird JT, von Deimling A, Louis DN.
    Cancer Res; 1996 Jan 01; 56(1):150-3. PubMed ID: 8548755
    [Abstract] [Full Text] [Related]

  • 5. Mutations of p16Ink4/CDKN2 and p15Ink4B/MTS2 genes in biliary tract cancers.
    Yoshida S, Todoroki T, Ichikawa Y, Hanai S, Suzuki H, Hori M, Fukao K, Miwa M, Uchida K.
    Cancer Res; 1995 Jul 01; 55(13):2756-60. PubMed ID: 7796400
    [Abstract] [Full Text] [Related]

  • 6. Replacement of the p16/CDKN2 gene suppresses human glioma cell growth.
    Arap W, Nishikawa R, Furnari FB, Cavenee WK, Huang HJ.
    Cancer Res; 1995 Mar 15; 55(6):1351-4. PubMed ID: 7882335
    [Abstract] [Full Text] [Related]

  • 7. Genetic alterations associated with glioma progression.
    Kleihues P, Lübbe J, Watanabe K, von Ammon K, Ohgaki H.
    Verh Dtsch Ges Pathol; 1994 Mar 15; 78():43-7. PubMed ID: 7534015
    [Abstract] [Full Text] [Related]

  • 8. Frequent p16INK4 (MTS1) gene inactivation in testicular germ cell tumors.
    Chaubert P, Guillou L, Kurt AM, Bertholet MM, Metthez G, Leisinger HJ, Bosman F, Shaw P.
    Am J Pathol; 1997 Sep 15; 151(3):859-65. PubMed ID: 9284835
    [Abstract] [Full Text] [Related]

  • 9. Inactivation of p16INK4 in hepatocellular carcinoma.
    Hui AM, Sakamoto M, Kanai Y, Ino Y, Gotoh M, Yokota J, Hirohashi S.
    Hepatology; 1996 Sep 15; 24(3):575-9. PubMed ID: 8781327
    [Abstract] [Full Text] [Related]

  • 10. Hypermethylation of the CpG island of p16/CDKN2 correlates with gene inactivation in gliomas.
    Fueyo J, Gomez-Manzano C, Bruner JM, Saito Y, Zhang B, Zhang W, Levin VA, Yung WK, Kyritsis AP.
    Oncogene; 1996 Oct 17; 13(8):1615-9. PubMed ID: 8895506
    [Abstract] [Full Text] [Related]

  • 11. Analysis of the Rb gene and cyclin-dependent kinase 4 inhibitor genes (p16INK4 and p15INK4B) in human ovarian carcinoma cell lines.
    Yaginuma Y, Hayashi H, Kawai K, Kurakane T, Saitoh Y, Kitamura S, Sengoku K, Ishikawa M.
    Exp Cell Res; 1997 Jun 15; 233(2):233-9. PubMed ID: 9194486
    [Abstract] [Full Text] [Related]

  • 12. p16 overexpression: a potential early indicator of transformation in ovarian carcinoma.
    Shigemasa K, Hu C, West CM, Clarke J, Parham GP, Parmley TH, Korourian S, Baker VV, O'Brien TJ.
    J Soc Gynecol Investig; 1997 Jun 15; 4(2):95-102. PubMed ID: 9101469
    [Abstract] [Full Text] [Related]

  • 13. MTS1/p16/CDKN2 lesions in primary glioblastoma multiforme.
    Moulton T, Samara G, Chung WY, Yuan L, Desai R, Sisti M, Bruce J, Tycko B.
    Am J Pathol; 1995 Mar 15; 146(3):613-9. PubMed ID: 7887443
    [Abstract] [Full Text] [Related]

  • 14. Molecular analysis of P16(Ink4)/CDKN2 and P15(INK4B)/MTS2 genes in primary human testicular germ cell tumors.
    Heidenreich A, Gaddipati JP, Moul JW, Srivastava S.
    J Urol; 1998 May 15; 159(5):1725-30. PubMed ID: 9554401
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.